Cover Image
市場調查報告書

玻璃娃娃(成骨不全症):全球臨床實驗趨勢

Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339710
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
玻璃娃娃(成骨不全症):全球臨床實驗趨勢 Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015
出版日期: 2015年08月19日 內容資訊: 英文 87 Pages
簡介

本報告提供成骨不全症臨床實驗相關之最新趨勢分析,提供您各地區的主要國家臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,以及潛力藥劑比較等資訊。

簡介

  • 成骨不全症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:遺傳性疾病治療藥臨床實驗上成骨不全症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:遺傳性疾病治療藥臨床實驗上成骨不全症的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

成骨不全症治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Eli Lilly and Company
    • Axellus A/S
    • Arthritis Research UK
    • Amgen Inc.
    • Allergan Plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • Hospital de Cruces
    • Indiana University School of Medicine
    • Oregon Health & Science University
    • Peking Union Medical College Hospital
    • Shriners Hospitals for Children
    • St. Jude Children's Research Hospital, Inc.
    • 東北大學大學院醫學系研究科·醫學系
    • University of Cologne

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2836CTIDB

GlobalData's clinical trial report, "Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015" provides an overview of Osteogenesis Imperfecta clinical trials scenario. This report provides top line data relating to the clinical trials on Osteogenesis Imperfecta. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Osteogenesis Imperfecta
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Osteogenesis Imperfecta Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Axellus A/S
      • Clinical Trial Overview of Axellus A/S
      • Arthritis Research UK
      • Clinical Trial Overview of Arthritis Research UK
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
    • Clinical Trial Overview of Top Institutes / Government
      • Hospital de Cruces
      • Clinical Trial Overview of Hospital de Cruces
      • Indiana University School of Medicine
      • Clinical Trial Overview of Indiana University School of Medicine
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Peking Union Medical College Hospital
      • Clinical Trial Overview of Peking Union Medical College Hospital
      • Shriners Hospitals for Children
      • Clinical Trial Overview of Shriners Hospitals for Children
      • St. Jude Children's Research Hospital, Inc.
      • Clinical Trial Overview of St. Jude Children's Research Hospital, Inc.
      • Tohoku University School of Medicine
      • Clinical Trial Overview of Tohoku University School of Medicine
      • University of Cologne
      • Clinical Trial Overview of University of Cologne
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Region, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Osteogenesis Imperfecta Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Axellus A/S, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Arthritis Research UK, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Cruces, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking Union Medical College Hospital, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University School of Medicine, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2015*

List of Figures

  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Osteogenesis Imperfecta Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Osteogenesis Imperfecta Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top